Poly Medicure Limited 
Regd. Office : 232-B, 3'' Floor, Okhla Industrial Estate 
Phase-Ill, New Delhi - 110020 (INDIA) 
' 
T:_ :91-11 -33550:00, 47317000, F: +91-l l-26321894, 26321839 
E. info@polymed1cure.com W: polymedicure.com 
CIN: L40300DL1995PLC066923 
Date: 5TH Sept ember, 2023 
The Manager 
BSE Limited 
Corporate Relationship Department, 
l51 Floor, New Trading Ring, 
Phiroze Jeejeenhoy Towers, 
Dalal Street, Fort Mumbai, 
Maharashtra - 400001 
Dear Sir/Ma'am, 
The Manager 
National Stock Exchange of India Limited 
C-1, G-Block, 'Exchange Plaza', 
· Bandra - Kurla Complex, 
Maharashtra - 400051. 
Sub: Business Responsibility and Sustainability Report for the Financial Year 2022-23. 
Pursuant to Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) 
Regulations, 2015, please find enclosed the Business Responsibility and Sustainability Report ("BRSR") 
for the financial year 2022-23 which forms an integral part of the Annual Report of the Company for the 
financial year 2022-23. We request you to take the same on record. 
This is submitted for information and record please. 
Thanking You, 
Yours Faithfully, 
For Poly Medicure Limited 
Avinash Chandra 
Company Secretary 
Encl: As above 
Works : Plot No. l 04-105 & l ~ 5-116, Sector-59, ~lSIIDC Industrial Area, Ballabgarh, Faridabad - 121004 Haryana (INDIA) 
: +91-129-3355070, 4287000, F: +91 -129-2307007, 2309102 
' 
AVINASH 
CHANDRA
Digitally signed by 
AVINASH 
CHANDRA 
Date: 2023.09.05 
18:07:50 +05'30'
Annexure I 
BUSINESS RESPONSIBILITY & SUSTAINABILITY REPORTING FORMAT 
SECTION A: GENERAL DISCLOSURES 
I.
Details of the listed entity
1.
Corporate Identity Number (CIN) of the Listed Entity
L40300DL1995PLC066923
2.
Name of the Listed Entity
Poly Medicure Limited
3.
Year of incorporation
1995
4.
Registered office address
232-B, 3rd Floor, Okhla Industrial
Estate, New Delhi – 110020, INDIA
5.
Corporate address
232-B, 3rd Floor, Okhla Industrial
Estate, New
Delhi – 110020, INDIA
6.
E-mail
info@polymedicure.com
7.
Telephone
+ 91-11-26321889/93/99/38;
+91- 11-33550700;
+ 91-11-47687000
8.
Website
www.polymedicure.com
9.
Financial year for which reporting is being done
2022-23
10.
Name of the Stock Exchange(s) where shares are
listed
BSE Limited 
National Stock Exchange of India 
Limited 
11.
Paid-up Capital
Rs. 4797.23 Lacs
12.
Name and contact details (telephone, email address)
of the person who may be contacted in case of any
queries on the BRSR report
Mr. Ajay Singla (GM Finance) 
0129-4287000, 3355070 
ajay.singla@polymedicure.com 
13.
Reporting boundary 
Standalone basis
II.
Products/services
14.
Details of business activities (accounting for 90% of the turnover):
S. No.
Description of Main 
Activity 
Description of 
Business Activity 
% of Turnover of the entity
1. 
Manufacturing of Medical 
Devices 
Manufacturing of 
Medical Devices 
 100% 
15.
Products/Services sold by the entity (accounting for 90% of the entity’s Turnover):
S. No.
Product/Service 
NIC Code 
% of total Turnover contributed 
1 
Infusion Therapy 
46497 
67.60% 
2 
Blood Management 
46497 
9.84% 
3 
Other 
46497 
8.63% 
4 
Renal Care 
46497 
7.09% 
5 
Surgery and wound 
Drainage 
46497 
3.93% 
6 
Anaesthesia & 
Respiratory Care 
46497 
2.90% 
1
III.
Operations
16.
Number of locations where plants and/or operations/offices of the entity are situated:
Location
Number of Plants
Number of offices
Total
National
6 
1 
7 
International
3 
1 
4 
17.
Markets served by the entity:
a.
Number of locations
Locations 
Number 
National (No. of States) 
28 
International (No. of Countries) 
More than 120 countries across Globe 
b.
What is the contribution of exports as a percentage of the total turnover of the entity?
67.64%
c.
A brief on types of customers
We supplied our products to over 120 countries, in Europe, Africa, Americas, Australia,
and Asia through a network of over 250 distributors in these jurisdictions. We have also
have a country- wide sale and distribution network in India. We distributed our products
in over 6500 private and Govt. hospitals and nursing home in India.
IV.
Employees
18.
Details as at the end of Financial Year: 2022-23
a. Employees and workers (including differently abled):
S.
No.
Particulars
Total
(A) 
Male
Female
No. (B) 
% (B / A) 
No. (C) 
% (C / A) 
EMPLOYEES
1.
Permanent (D)
1093 
1003 
91.76% 
90 
8.23% 
2.
Other
than
Permanent (E) 
- 
- 
- 
- 
- 
3.
Total
employees
(D + E)
1093 
1003 
91.76% 
90 
8.23% 
WORKERS
4.
Permanent (F)
1168 
304 
26.02% 
864 
73.97% 
5.
Other
than
Permanent (G) 
3126 
2581 
82.56% 
545 
17.43% 
6.
Total workers
(F + G) 
4294 
2885 
67.18% 
1409 
32.81% 
2
b. Differently abled Employees and workers:
S.
No
Particulars
Total
(A) 
Male
Female
No. (B) 
% (B / A) 
No. (C) 
% (C / A) 
DIFFERENTLY ABLED EMPLOYEES
1.
Permanent (D)
1 
1 
100% 
- 
2.
Other
than 
Permanent (E)
- 
- 
- 
- 
3.
Total differently
abled employees
(D + E)
1 
1 
100% 
- 
DIFFERENTLY ABLED WORKERS
4.
Permanent (F)
- 
- 
- 
5.
Other
than
permanent (G)
- 
- 
- 
6.
Total differently 
abled workers 
(F + G) 
- 
- 
- 
19.
Participation/Inclusion/Representation of women
Total
(A) 
No. and percentage of Females
No. (B)
% (B / A)
Board of Directors 
12 
2 
16.66% 
Key
Management
Personnel 
3 
0 
0 
20.
Turnover rate for permanent employees and workers
(Disclose trends for the past 3 years)
FY 2022-23
(Turnover rate in current 
FY 2022-23) 
FY 2021-22 
(Turnover rate in 
previous FY 
2021-22) 
FY 2020-21 
(Turnover rate in the 
year 
prior 
to 
the 
previous FY 2020-21) 
Male
Female
Total
Male
Female
Total
Male
Female
Total
Permanent 
Employees 
13.65 
15.55 
13.81 
13.85 
13.84 
13.85 
 24.26 
 32.30 
 24.96
Permanent 
Workers 
20.06 
38.19 
33.47 
13.34 
8.95 
11.86 
 30.12 
 3.59 
 21.22
3
V.
Holding, Subsidiary and Associate Companies (including joint ventures)
21.
(a) Names of holding / subsidiary / associate companies / joint ventures
S.
No. 
Name of the 
holding 
/ 
subsidiary 
/ 
associate 
companies 
/ 
joint ventures 
(A) 
Indicate 
whether 
holding/ Subsidiary/ 
Associate/ 
Joint 
Venture 
% of shares 
held 
by 
listed 
entity 
Does the entity indicated at 
column A, participate in the 
Business 
Responsibility 
initiatives of the listed entity? 
(Yes/No) 
1 
Poly Medicure 
(Laiyang) Co. ltd. 
Subsidiary 
100 
The 
Company 
encourages 
its 
subsidiaries 
to 
undertake 
BR 
initiatives to the fullest extent in 
their operations. The Company’s
subsidiaries 
are 
incorporated
outside India and they comply with 
the local statutory requirements of
their respective countries. 
2 
Poly Medicure B.V. , 
Netherlands 
Subsidiary 
100 
3 
Plan1 Health India 
Pvt Ltd 
Subsidiary 
99.99 
4 
Ultra for Medical 
Products Company 
(ULTRAMED) 
Associate 
23 
VI.
CSR Details
22.
(i) Whether CSR is applicable as per section 135 of Companies Act, 2013: (Yes)
(ii) Turnover (in Rs.)    10,68,04,50,006/-
(iii) Net worth (in Rs.) 12,34,12,45,340/-
VII.
Transparency and Disclosures Compliances:
Company has compiled with all the mandatory requirements under the Listing Agreement
and SEBI (LODR) regulations, 2015.
23.
Complaints/Grievances on any of the principles (Principles 1 to 9) under the National
Guidelines on Responsible Business Conduct:
4
Stakeholder 
group from 
whom 
complaint is 
received 
Grievance 
Redressal 
Mechanism  in 
Place 
(Yes/No) 
FY 2022-23
Current Financial Year 
FY 2021-22
Previous Financial Year 
(If Yes, then 
provide web-link 
for grievance 
redress policy) 
Number of 
complaints  
filed during 
the  year 
Number of 
complaints 
pending 
resolution 
at close of 
the year 
Remarks Number of 
complaints 
filed during 
the  year 
Number of 
complaints 
pending 
resolution at 
close of the 
year 
Remarks 
Communities
As Mentioned 
hereunder 
 NIL 
 NIL 
Investors 
(other than 
shareholders) 
Shareholders#
Employees 
and workers 
Customers
Value Chain 
Partners 
# excludes the shareholders grievances/complaints with respect to the shares held by them, transfer of 
shares, non-receipt of the annual report, and the like. 
Customers 
Customer complaints with respect to Product Quality / Dispatches are mailed to the 
concerned Marketing team either directly or through dealers/agents attached to these 
customers with details on batch number, invoices etc. All such complaints are 
accorded priority and then escalated to the concerned QC team at the plant (product 
quality related) or Sales Logistics team (dispatch related). For Quality related 
complaints, the concerned QC team members also visit the customer depending on the 
seriousness of the complaint and suggest corrective action either directly at the 
customer site or by analysing the samples of the affected material at our lab. 
Shareholders There is a strong grievance redressal mechanism for shareholders & investors 
regarding the shares held by them. The complaints are attended promptly by the R & 
T agents and secretarial team. The Stakeholders Relationship Committee of the Board 
oversees and looks into grievances not resolved in the specified time frame 
Employees & 
Workers 
The Human Resources department of the Company has laid down the system to 
address the grievances of employees and workers. Their complaints can be submitted 
to the HR head and plant head through emails or suggestion boxes. The Company has 
also put in place Whistle Blower Policy and mechanism to enable the employees to 
raise their concerns, wrongdoing, and other irregularities noticed in the Company 
without any fear of reprisal or reprimand. 
Value Chain 
Partners & 
Communities
For value chain partners and communities, the complaints/Grievances on any of the 
principles - Principles 1 to 9 under the National Guidelines on Responsible Business 
Conduct, can be registered by mailing to info@polymedicure.com or by sending to 
respective plant heads or functional heads. The same is attended promptly by the 
concerned functional heads or location heads to resolve it. If any complaints remain 
unresolved within a reasonable time, the same is referred to the top management for 
resolution 
5
24.
Overview of the entity’s material responsible business conduct issues
Please indicate material responsible business conduct and sustainability issues pertaining to 
environmental and social matters that present a risk or an opportunity to your business, rationale 
for identifying the same, approach to adapt or mitigate the risk along-with its financial implications, 
as per the following format 
S.
No. 
Material issue 
identified 
Indicate 
whether risk 
or 
opportunity 
(R/O) 
Rationale 
for 
identifying 
the risk/ 
opportunity 
In case of  risk, 
approach to  adapt or 
mitigate 
Financial 
implications 
of the risk or 
opportunity 
(Indicate 
positive or  
negative 
implications) 
1
Environmental
risk 
Risk 
Climate 
plays an 
essential role 
in Driving 
the 
Company’s 
business. 
Foreseeing 
climatic 
change and 
predicting 
the demand 
for certain 
products is 
complex 
Polymed hold more 
than 25 years of  
experience in medical 
devices industry, and 
has gained strong 
insights about the 
countries,where it 
operates. 
Negative 
2
Reducing the 
Carbon 
Footprint of 
our Operations
Risk & 
Opportunity
Incresing 
focus by the 
public and 
industry for 
reducing 
Carbon 
footprint on 
the 
principles of 
sustainabilit
y 
Increasingly, a low 
carbon footprint is 
viewd very positively 
by all the 
stakeholders, and 
reducing the footprint 
will yield benefits on 
multiple fonts. 
The Company has 
been measuring and 
focusing on reducing 
the carbon footprint at 
various facilities, 
through many 
energy-saving 
schemes. The last few 
years have seen a 
reduction in the 
footprint. 
Positive 
6
3
Health and 
Safety of 
employees 
and nearby 
Communities
Risk 
Exposure to 
chemicals 
can lead to 
health 
issues to 
employees 
and 
communities
. 
Implementation of 
Process Safety 
Management System 
to ensure system 
healthiness thereby 
minimizing incidents. 
Robust emergency 
preparedness plan 
and conduct of 
periodic mock drills. 
Negative
4
Managing 
impacts of 
water stress 
on local 
Risk 
To mitigate 
impacts of 
water stress 
on the 
community.
The Company, has 
over the years, been 
focused on reducing 
water intake and 
consumption. All the 
sites have zero liquid 
Discharge facilities, 
these ensure that the 
entire liquid effluent 
is treated and reused, 
thereby reducing 
fresh withdrawal. 
Negative 
5
Operational 
Risk 
Risk 
The value 
chain of the 
Company’s 
business 
comprises 
people, 
systems, 
processes, 
external and 
internal 
events, legal 
and 
compliance 
risk. These 
are integral 
to the 
business’ 
operations, 
and, 
thereon, 
pose a 
risk for the 
Company. 
The Company has 
taken measures to 
cover patent 
extension risk by 
seeking multiple 
registrations from 
different geographies 
Negative 
6
Ethics & 
Governance 
Opportunity
Good 
governance 
assists in 
luring and 
keeping 
talent and 
The Company 
encourages, protects 
and recognises 
‘Whistle blowing’ to 
prevent brand and 
Neutral 
7
also 
committed 
to creating a 
great 
working 
environment
. Ethical and 
strong 
governance 
helps 
to improve 
the brand 
value and 
also helps 
streamline 
business 
operations. 
reputational risks and 
also has zero tolerance 
policy 
for statutory non- 
compliance. 
SECTION B: MANAGEMENT AND PROCESS DISCLOSURES 
This section is aimed at helping businesses demonstrate the structures, policies and processes 
put in place towards adopting the NGRBC Principles and Core Elements. 
Disclosure
Questions 
P
1 
P
2 
P
3 
P
4 
P
5 
P
6 
P
7 
P
8 
P
9 
Policy and management processes
1. a. Whether your entity’s policy/policies cover
each principle and its core elements of the 
NGRBCs. (Yes/No) 
YES 
b. Has the policy been approved by the
Board? (Yes/No)
c. Web Link of the Policies, if available
www.polymedicure.com 
2. Whether the entity has translated the
policy into procedures. (Yes / No)
YES 
3. Do the enlisted policies extend to your
value chain partners? (Yes/No)
4. Name of the national and international
codes/certifications/labels/ standards (e.g.
Forest Stewardship Council, Fairtrade,
Rainforest Alliance, Trustea) standards (e.g.
SA 8000, OHSAS, ISO, BIS) adopted by your
entity and mapped to each principle.
 ISO 9001:2015 & ISO 13485:2016 
5.
Specific commitments, goals and targets
set by the entity with defined timelines, if
any.
The Company is committed to adhering to these
principles to maintain the highest standard in levels
of operations and it is an ongoing process. 
6. Performance of the entity against the
specific commitments, goals and targets
along-with reasons in case the same are
not met.
Performance of each of the principles is reviewed 
periodically by the Management. 
8
Governance, leadership and oversight
7.
Statement by director responsible for the business responsibility report, highlighting ESG
related challenges, targets and achievements
Polymed is dedicated to promote ESG principals into its business operations. We strive to
deliver safe and superior-quality products to both the medical community and patients,
ensuring comprehensive care at every step. Our manufacturing process for medical
devices takes place in a controlled clean room environment, utilizing highly sophisticated
equipment and technology. By incorporating automated machinery technology, we can
produce the most cost-effective devices possible. As part of our commitment to
sustainability, our comprehensive sustainable strategy is geared towards fostering a low-
carbon society by diminishing greenhouse gas emissions, conserving natural resources,
and fostering social progress. We have also incorporated recycled paper in our cartons,
contributing to our efforts in this direction. Additionally, we utilize plastics within specified
proportions, ensuring they do not compromise the functionality of our products.
8. Details of the highest authority responsible
for implementation and oversight of the
Business Responsibility policy(ies).
All the policies have been formulated in 
consultation with the Management of the 
Company and are approved by the Board. 
Policies are prepared enduring adherence to 
applicable laws/rules/regulations and are 
approved by the Board. The Board reviews 
the policies from time to time as and when 
necessary. The implementation of policies 
wherever applicable, the Board overseen the 
implementation of such policy/policies. 
9. Does the entity have a specified Committee
of the Board/ Director responsible 
for
decision making on sustainability related
issues? (Yes / No). If yes, provide details.
CSR Committee looks at community/ social 
related initiatives, and for sustainability 
related activities within the organization. 
10. Details of Review of NGRBCs by the Company:
Subject for Review
Indicate whether review was
undertaken by Director / 
Committee of the Board/ 
Any other Committee 
Frequency
(Annually/ 
Half 
yearly/ 
Quarterly/ Any other – please 
specify) 
P
1
P
2
P
3
P
4
P
5
P
6
P
7
P
8
P
9
P
1 
P
2 
P
3 
P
4 
P
5 
P
6 
P
7
P
8 
P
9 
Performance
against
above 
policies 
and 
follow up action 
Y Y Y Y Y Y Y Y Y 
Annually 
Compliance
with
statutory requirements 
of relevance to the 
principles, 
and, 
rectification of any 
non-compliances 
Y Y Y Y Y Y Y Y Y 
Compliance 
with 
Statutory 
requirements of relevance to the 
principals 
is 
being 
reviewed 
periodically and non-compliance, if 
any being addressed with remedial 
actions as appropriate.  
9
11. Has the entity carried out independent
assessment/ evaluation of the working of its
policies by an external agency? (Yes/No). If yes,
provide name of the agency.
P 
1 
P 
2 
P 
3 
P 
4 
P 
5 
P 
6 
P 
7 
P 
8 
P 
9 
No 
12. If answer to question (1) above is “No” i.e. not all Principles are covered by a policy,
reasons to be stated: N.A.
Questions 
P
1 
P
2 
P
3 
P
4 
P
5 
P
6 
P
7 
P
8 
P
9 
The entity does not consider the Principles
material to its business (Yes/No) 
The entity is not at a stage where it is in a 
position to formulate and implement the 
policies on specified principles (Yes/No) 
The
entity
does
not
have
the
financial
or/human and technical resources available for 
the task (Yes/No) 
It is planned to be done in the next financial
year (Yes/No) 
Any other reason (please specify) 
SECTION C: PRINCIPLE WISE PERFORMANCE DISCLOSURE 
This section is aimed at helping entities demonstrate their performance in integrating the 
Principles and Core Elements with key processes and decisions. The information sought is 
categorized as “Essential” and “Leadership”. While the essential indicators are expected to be 
disclosed by every entity that is mandated to file this report, the leadership indicators may be 
voluntarily disclosed by entities which aspire to progress to a higher level in their quest to be 
socially, environmentally and ethically responsible. 
10
PRINCIPLE 1 Businesses should conduct and govern themselves with 
integrity, and in a manner that is Ethical, Transparent and 
Accountable. 
Essential Indicators
1.
Percentage coverage by training and awareness programmes on any of the Principles
during the financial year:
2.
Details of fines / penalties /punishment/ award/ compounding fees/ settlement amount
paid in proceedings (by the entity or by directors / KMPs) with regulators/ law
enforcement agencies/ judicial institutions, in the financial year, in the following format
(Note: the entity shall make disclosures on the basis of materiality as specified in Regulation 30
of SEBI (Listing Obligations and Disclosure Obligations) Regulations, 2015 and as disclosed on
the entity’s website):
Monetary
NGRBC
Principle 
Name of the
regulatory/ 
enforcement 
Amount (In 
INR) 
Brief of the Case
Has an
appeal 
been 
agencies/
judicial 
institutions 
preferred? 
(Yes/No) 
Penalty/ Fine
NA 
NA 
Nil 
NA 
No 
Settlement 
NA 
NA 
Nil 
NA 
No 
Compounding
fee 
NA 
NA 
Nil 
NA 
No 
 Non-Monetary
Segment 
Total 
number 
of 
training  
and 
awareness 
programmes held 
Topics
/
principles 
covered 
under 
the training and 
its impact 
%age of persons in 
respective category 
covered 
by 
the 
awareness 
programmes 
Board of 
Directors 
 
Key
Managerial 
Personnel 
 
Employees 
other than 
BoD and 
KMPs 
 
Workers
 
 4 
Business 
Sustainability 
 95% 
 4 
Business 
Sustainability 
 100% 
 16 
Problem Solving,
Engineering 
Material, GDP,   
 90.67% 
 3 
Nayi Disha 
 68.52% 
11
NGRBC
Principle 
Name of the 
regulatory/ 
enforcement 
agencies/ 
judicial 
institutions 
Brief of the Case
Has an appeal been 
preferred? (Yes/No) 
Imprisonment
NA 
NA 
NA 
No 
Punishment 
NA 
NA 
NA 
No 
3.
Of the instances disclosed in Question 2 above, details of the Appeal/ Revision
preferred in cases where monetary or non-monetary action has been appealed.
Case Details 
Name of the regulatory/enforcement 
agencies/judicial Institutions 
NA 
NA 
4. Does the entity have an anti-corruption or anti-bribery policy? If yes, provide details in
brief and if available, provide a web-link to the policy.
Yes, company has framed various codes and policies, which act as guiding principles
for carrying business in ethical way.
Some of policy are:

Code of conduct for Directors and Seniors Management Personnel

Code of Conduct for prevention of insider trading

Whistle Blower Policy
       https://www.polymedicure.com/wp-content/uploads/2023/02/vigil-mechanism-and-
whistle-blower-policy.pdf  
5. Number of Directors/KMPs/employees/workers against whom disciplinary action was
taken by any law enforcement agency for the charges of bribery/ corruption:
 
 
6.
Details of complaints with regard to conflict of interest:
F.Y 2022-23
F.Y 2021-22
Number
Remarks
Number
Remarks
Number 
of 
complaints
received in 
relation 
to 
issues 
of 
Conflict 
of
Interest of the Directors 
Nil 
Nil 
0 
FY 2022-23
(Current Financial Year) 
FY 2021-22
(Previous Financial Year) 
Directors
Nil 
Nil 
KMPs
Nil 
Nil 
Employees
Nil 
Nil 
Workers 
Nil 
Nil 
12
Number 
of 
complaints
received in 
relation 
to 
issues 
of 
Conflict 
of
Interest of the KMPs 
Nil 
Nil 
0 
7.
Provide details of any corrective action taken or underway on issues related to fines /
penalties / action taken by regulators/ law enforcement agencies/ judicial institutions, on
cases of corruption and conflicts of interest. Nil
Leadership Indicators
1.
Awareness programmes conducted for value chain partners on any of the Principles
during the financial year:
Suppliers’ code of conduct document published and acknowledgments are being received. This
document comprises Statutory compliance, Environmental compliances, Child labor, Anti-bribery
etc. The Company strongly believes and insists that its value chain partners adhere to all the
business responsibility principles and values of transparency and accountability.
2.
Does the entity have processes in place to avoid/ manage conflict of interests involving
members of the Board? (Yes/No) If Yes, provide details of the same.
Yes- Microsoft Word - CODE OF CONDUCT (polymedicure.com)
Yes, the company has a well established process in order to manage existing as well as potential
conflicts which may arise in due course of business between the company, its directors and
employees.
The directors, on annual basis, provide a declaration with respect to entities they are interested
in as per the requirement of statute. The company ensures that necessary approvals for
transacting with such individuals are takes as per the requirement of statute and Company’s
policy.
Total number of awareness 
held 
Topics / principles covered 
under the training 
%age of value chain 
programmes partners 
covered (by value of 
business done with such 
partners) under the 
awareness programmes
 73 
 Supplier Quality System 
 53.76% 
13
PRINCIPLE 2 Businesses should provide goods and services in a 
manner that is sustainable and safe 
 Essential Indicators
1.
Percentage of R&D and capital expenditure (capex) investments in specific technologies to improve the
environmental and social impacts of product and processes to total R&D and capex investments made
by the entity, respectively.
2.
a. Does the entity have procedures in place for sustainable sourcing? (Yes/No)
b. If yes, what percentage of inputs were sourced sustainably?
 Yes- >70% 
 To promote sustainable sourcing, the Company has built sustainability concern into its processes for vendor
development and procurement management. We have procedures in place for our raw material supplies,
supplementary materials, packing materials, transportation services and spares which are sourced from approved
suppliers. The Company always tries to source materials from nearby venders and if not available then approaches
other venders.  
3.
Describe the processes in place to safely reclaim your products for reusing, recycling and disposing at
the end of life, for (a) Plastics (including packaging) (b) E-waste (c) Hazardous waste and (d) other waste.
The Company adheres to the requirements of Plastic Waste Management Rules laid down by the Central Pollution
Control Board. We have registered in the EPR (Extended Producers Responsibility) portal of CPCB. We also have
processes in place for disposing of recyclable waste like e-waste, hazardous waste, and other wastes to State
Pollution Control Board (SPCB) and authorized agencies.
The Company has a plan in order to manage its plastic waste/E-waste/Hazardous waste/other waste
wherein an authorized recycler or authorized third party collects waste from the plant and responsibly
recycles/disposes it.
4.
Whether Extended Producer Responsibility (EPR) is applicable to the entity’s activities (Yes / No). If yes,
whether the waste collection plan is in line with the Extended Producer Responsibility (EPR) plan
submitted to Pollution Control Boards? If not, provide steps taken to address the same.
Yes, All the Plants have registered in the Extended Producer Responsibility (EPR) Portal of CPCB towards
compliance with Plastic Waste Management Rules, 2016 and subsequent amendments under “Brand
Owner” as well as “Importer”.
Current 
Financial Year 
Previous 
Financial Year 
Details 
of 
improvements in 
  environmental and 
social impacts 
R&D
The Company, through R& D activities works on 
improving the yields in all processes and focuses on 
reduction of consumption of water and air. 
Capex
1.62% 
2.93% 
14
Leadership Indicators 
1.
Has the entity conducted Life Cycle Perspective / Assessments (LCA) for any of its products
(for manufacturing industry) or for its services (for service industry)? If yes, provide details in
the following format?
NIC Code
Name 
of 
Product 
/ 
Service 
% 
of 
total 
Turnover 
contributed 
Boundary for 
which 
the 
Life 
Cycle 
Perspective / 
Assessment 
was 
conducted 
Whether 
conducted by 
independent 
external 
agency 
(Yes/No) 
Results 
communicated 
in 
public 
domain 
(Yes/No) 
If yes, provide 
the web-link. 
NA
2.
If there are any significant social or environmental concerns and/or risks arising from
production or disposal of your products / services, as identified in the Life Cycle Perspective /
Assessments (LCA) or through any other means, briefly describe the same along-with action
taken to mitigate the same.
Name of Product / Service
Description of the risk
/
concern 
Action Taken
NIL
NA
NA
3.
Percentage of recycled or reused input material to total material (by value) used in
production (for manufacturing industry) or providing services (for service industry)
Indicate input material
Recycled or re-used input material to total material
FY2022-23 (Current Financial 
Year) 
FY2021-22(Previous Financial 
Year) 
Nil
Nil
4.
Of the products and packaging reclaimed at end of life of products, amount (in metric tonnes)
reused, recycled, and safely disposed, as per the following format:
FY 2022-23 (Current Financial Year)
FY
2021-22
(Previous
Financial 
Year) 
Re-Used
Recycled
Safely 
Disposed 
Re-Used
Recycled
Safely 
Disposed 
Plastics(including 
packaging) 
0
0
1297.46
0
0
957.27
E-waste
0
0
0
0
0
0
Hazardous waste
0
0
0
0
0
0
Other waste
0
0
142.32
0
0
159.14
5.
Reclaimed products and their packaging materials (as percentage of products sold) for each
product category:
Indicate Product category
Reclaimed products and their packaging materials 
as % of total products sold in respective category 
NA
NIL
15
PRINCIPLE 3 Businesses should respect and promote the well-being 
of all employees, including those in their value chains 
Essential Indicators
1. a. Details of measures for the well-being of employees:
b. Details of measures for the well-being of workers:
2. Details of retirement benefits, for Current FY and Previous Financial Year.
Benefits
FY 2022-23 
Current Financial Year 
FY 2021-22 
Previous Financial Year 
No. 
of 
employees 
covered as 
a    %  of 
total 
employees
No. 
of 
workers 
covered 
as a % of 
total 
workers 
Deducted 
and 
deposited 
with 
the 
authority 
(Y/N/N.A.) 
No. 
of 
employees 
covered as 
a    %    of 
total 
employees 
No.
of
workers 
covered as a 
% of total 
workers 
Deducted and 
deposited with 
the authority 
(Y/N/N.A.) 
PF
100% 
100% 
Y 
100% 
100% 
Y 
Category 
% of employees covered by
Total
(A) 
Health
insurance 
Accident
insurance 
Maternity
benefits 
Paternity
Benefits 
Day Care
facilities 
Number 
(B) 
% (B / 
A) 
Number 
(C) 
% (C / 
A) 
Number 
(D) 
% (D / 
A) 
Number 
(E) 
% (E / 
A) 
Number 
(F) 
% (F / 
A) 
Permanent employees
Male
Female
Total
Other than Permanent employees
Male
Female
Total
Category
% of workers covered by
Total
(A) 
Health
insurance 
Accident
insurance 
Maternity
benefits 
Paternity
Benefits 
Day Care
facilities 
Number 
(B) 
% (B / 
A) 
Number 
(C) 
% (C / 
A) 
Number 
(D) 
% (D / 
A) 
Number 
(E) 
% (E / 
A) 
Number 
(F) 
% (F / 
A) 
Permanent workers
Male
Female
Total
Other than Permanent workers
Male
Female
Total
1003 
1003 
100% 
1003 
100% 
0 
0 
0 
90 
90 
100% 
90 
100% 
90 
100% 
0 
0 
1093 
1093 
1093 
90 
0 
0 
-
- 
-
- 
 - 
- 
 - 
- 
-
- 
-
- 
 - 
- 
 - 
- 
 - 
- 
 - 
- 
 - 
- 
 - 
- 
 - 
- 
 - 
- 
 - 
- 
 - 
- 
 - 
304 
304 
100%
304 
100% 
0 
0% 
0 
0 
864 
864 
100%
864 
100% 
864 
100% 
0 
0 
1168 
1168 
-
1168
864 
0 
0 
 
2581 
2581 
100%
- 
- 
0 
0% 
0 
0 
545 
545 
100%
-
- 
545
100% 
0 
0 
3126 
3126 
- 
- 
545 
0 
0 
16
Gratuity
100% 
100% 
Y 
100% 
100% 
Y 
ESI
39.7% 
94.89% 
Y 
9.86% 
97.25% 
Y 
Others – 
please 
specify 
3. Accessibility of workplaces
Are the premises / offices of the entity accessible to differently abled employees and
workers, as per the requirements of the Rights of Persons with Disabilities Act, 2016? If
not, whether any steps are being taken by the entity in this regard.
Yes, the premises/offices of Poly Medicure Limited are largely accessible to differently abled
employees and workers in accordance with Rights of Persons with Disabilities Act, 2016. The
Company ensures that requisite infrastructure and facilities are in place for people with special
needs.
4.
Does the entity have an equal opportunity policy as per the Rights of Persons with
Disabilities Act, 2016? If so, provide a web-link to the policy.
Yes, the Company has an equal opportunity policy in place as a part of its BRSR which can be
accessed.
It aims to provide equal opportunities in employment and setting a workplace culture where all
employees are treated with respect and are not discriminated or harassed on the basis of race, colour, 
religion, disability, gender, national origin, sexual orientation, gender identity, gender expression, 
age, genetic information, military status, or any other legally protected status. 
5.
Return to work and Retention rates of permanent employees and workers that took
parental leave.
6.
Is there a mechanism available to receive and redress grievances for the following
categories of employees and worker? If yes, give details of the mechanism in brief: Yes
Permanent Workers 
The company sets a culture which encourages 
open 
and 
transparent 
communication. 
Employees are encouraged to raise their 
concerns and discuss it freely with HOD’s or HR.  
The Company has a vigil mechanism policy as per 
the requirement of Section 177 of the Companies 
Act, 2013 and Regulation 22 of SEBI (Listing 
Obligations 
and 
Disclosure 
Requirements) 
Regulations, 2015 which allows its directors and 
employees to report its genuine concerns about 
unethical behavior, actual or suspected fraud or 
any violation, 
and 
provides for 
adequate 
safeguards against victimization of persons who 
uses such mechanism. It also provides for direct 
access to the chairperson of the Audit Committee 
in appropriate or exceptional cases. 
Other than Permanent Workers 
Permanent Employees 
Other than Permanent Employees 
Permanent employees
Permanent workers
Gender 
Return to work 
rate 
Retention rate
Return to work 
rate 
Retention rate
Male
100% 
100% 
100% 
100% 
Female
100% 
100% 
100% 
100% 
Total
100% 
100% 
100% 
100% 
17
The policy can be accessed https://www.polymedicure.com/wp-content/uploads/2023/02/vigil-
mechanism-and-whistle-blower-policy.pdf 
7.
Membership of employees and worker in association(s) or Unions recognised by the
listed entity:
The Company does not have any employee associations. However, the Company respects
and recognises employees’ rights to freedom to peaceful association and collective
bargaining.
Category
FY 2022-23
(Current Financial Year) 
FY 2021-22
(Previous Financial Year) 
Total
employees / 
workers 
in 
respective 
category 
(A) 
No. of employees /
Workers in 
respective 
category, who are 
part 
of 
association(s) 
or 
Union 
(B) 
% (B / A)
Total
employees 
/ workers 
in 
respective 
category 
(C) 
No.
of
employees 
/ 
workers 
in 
respective 
category, who 
are 
part 
of 
association(s) 
or Union 
(D) 
% (D /
C)
18
Total
Permanent 
Employees 
-
Male
N/A 
N/A 
N/A 
N/A 
-
Female
N/A 
N/A 
N/A 
N/A 
Total 
Permanent 
Workers 
-
Male
N/A 
N/A 
N/A 
N/A 
-
Female
N/A 
N/A 
N/A 
N/A 
8.
Details of training given to employees and workers:
9.
Details of performance and career development reviews of employees and worker:
10. Health and safety management system:
a.
Whether an occupational health and safety management system has been
implemented by the entity? (Yes/ No). If yes, the coverage such system?
Yes,
a.
What are the processes used to identify work-related hazards and assess risks on a
routine and non-routine basis by the entity?  Safety Audit by CFT
b.
Whether you have processes for workers to report the work related hazards and to
remove themselves from such risks. (Y/N) Yes by Kaizen scheme
Category
FY
Current Financial Year 
FY
Previous Financial Year 
Total 
(A) 
On
Health
and safety 
measures 
On
Skill
upgradation 
Total 
(D) 
On Health and 
safety measures 
On Skill upgradation
No.
(B) 
% (B
/ A) 
No.
(C) 
% (C /
A) 
No.
(E) 
% (E / D)
No. (F)
% (F / D)
Employees
Male
 
 
Female
 
 
Total
 
 
Workers
Male
Female
Total
Category
FY
Current Financial Year 
FY
Previous Financial Year 
Total 
(A) 
No. (B)
% (B / A)
Total 
(C) 
No. (D)
% (D / C)
Employees
Male
Female
Total
Workers
Male
 
Female
 
Total
       2022-23
       2021-22
1003 
485 
48.35%
485 
48.35% 
857 
410 
  47.84% 
410 
 47.84% 
90 
40 
44.44%
40 
44.44% 
83 
35 
42.16% 
35 
  42.16% 
1093 
525 
48.03%
525 
48.03% 
940 
445 
47.34% 
445 
47.34% 
 
304 
304 
100% 
304 
100% 
293 
293 
100% 
293 
100% 
864 
864 
100% 
864 
100% 
904 
904 
100% 
904 
100% 
1168 
1168 
100% 
1168 
100% 
2797 
2182 
100% 
1669 
100% 
       2022-23
        2021-22
1003 
1003 
 100% 
857
857
100% 
90 
90 
100% 
83
83
100% 
1093 
1093 
100% 
940
940
100% 
 
2885 
2885 
100% 
1197 
1197 
100% 
1409 
1409 
100% 
2298 
2298 
100% 
4294 
4294 
100% 
3495 
3495 
100% 
19
d. Do the employees/ worker of the entity have access to non-occupational medical
and healthcare services? (Yes/ No)  Yes
11. Details of safety related incidents, in the following format:
Safety Incident/Number 
Category
 FY 2022-23
Current Financial 
Year 
 FY  2021-22   
Previous Financial 
Year 
Lost Time Injury Frequency Rate 
(LTIFR) 
(per one 
million-person 
hours worked) 
Employees
Nil 
Nil 
Workers
Nil 
Nil 
Total 
recordable 
work-related 
injuries 
Employees
Nil 
Nil 
Workers 
Nil 
Nil 
No. of fatalities 
Employees 
Nil 
Nil 
Workers
Nil 
Nil 
High 
consequence 
work-related 
injury 
or 
ill-health 
(excluding 
fatalities) 
Employees
Nil 
Nil 
Workers
Nil 
Nil 
12. Describe the measures taken by the entity to ensure a safe and healthy work place.
Safety Audit, Work Instructions, Safety Training, Poka Yoka on Machine
13. Number of Complaints on the following made by employees and workers:
FY 2022-23
(Current Financial Year) 
FY 2021-22
(Previous Financial Year) 
Filed during 
the year 
Pending 
resolution 
at the end 
of year 
Remarks 
Filed 
during the 
year 
Pending 
resolution 
at the end 
of year 
Remarks
Working 
Conditions 
Nil 
Nil 
Nil 
Nil 
Health 
& 
Safety 
Nil 
Nil 
Nil 
Nil 
14. Assessments for the year:
% of your plants and offices that were assessed 
(by entity or statutory authorities or third parties) 
Health and safety practices
100% 
Working Conditions
100% 
15. Provide details of any corrective action taken or underway to address safety-related
incidents (if any) and on significant risks / concerns arising from assessments of health
& safety practices and working conditions.
Replaced old Fire  Equipment with new Equipments,
Necessary step have been taken to ensure that there is no obstacle in the passage.
20
Leadership Indicators 
1. Does the entity extend any life insurance or any compensatory package in the event of
death of (A) Employees (Y/N) (B) Workers (Y/N). Yes
2.
Provide the measures undertaken by the entity to ensure that statutory dues have been
deducted and deposited by the value chain partners.
Yes, through audit of Value Chain Partner
3.
Provide the number of employees / workers having suffered high consequence work- 
related injury / ill-health / fatalities (as reported in Q11 of Essential Indicators above),
who have been are rehabilitated and placed in suitable employment or whose family
members have been placed in suitable employment:
Total 
no. 
of 
affected 
employees/ workers 
No. of employees/workers that are 
rehabilitated and placed in suitable 
employment or whose family members 
have 
been 
placed 
in 
suitable 
Employment 
FY 
2022-23 
(Current 
Financial 
Year)
FY 
2021-22 
(Previous 
Financial 
Year)
FY 2022-23 
(Current Financial 
Year) 
FY 2021-22    
(Previous 
Financial Year) 
Employees
Nil 
Nil 
Nil 
Nil 
Workers
Nil 
Nil 
Nil 
Nil 
4. Does the entity provide transition assistance programs to facilitate continued
employability and the management of career endings resulting from retirement or
termination of employment? (Yes/ No) No
5.
Details on assessment of value chain partners:
% of value chain partners (by value of business done 
with such partners) that were assessed 
Health and safety practices
 53.76% 
Working Conditions
 53.76% 
6.
Provide details of any corrective actions taken or underway to address significant risks /
concerns arising from assessments of health and safety practices and working conditions
of value chain partners.
The Company provides adequate trainings through audits to vendors for
improving health and safety conditions at work place.
21
PRINCIPLE 4: Businesses should respect the interests of and be 
responsive to all its stakeholders
1.
Describe the processes for identifying key stakeholder groups of the entity.
Any entity, group of individuals or institution that gives value to the Company’s business chain or that
is impacted by us is recognised as a key stakeholder.
Following are the attributes of key stakeholders:
Stakeholders who are directly dependent on the organisational activities, products, services or on whom 
the organisation is dependent to operate. 
 Stakeholders towards whom the organisation has legal, commercial, operational or moral responsibility. 
2.
Key stakeholder groups and the frequency of engagement with each stakeholder group.
Stakeholder
Group 
Whether identified 
as Vulnerable & 
Marginalised Group 
(Yes / No) 
Channels of 
communication 
(Email, SMS, 
Newspaper, 
Pamphlets, 
Advertisement, 
Community 
Meetings, Notice 
Board, Website) 
Frequency of
Engagement 
(Annually / Half 
yearly / Quarterly / 
others) 
Purpose and scope 
of engagement 
Shareholders 
NO 
Annual General 
Meeting, shareholder 
meets, emails, Stock 
Exchange (SE) 
intimations, investor / 
analysts meet / 
conference calls, 
annual report, 
quarterly results, 
media 
releases, Company / 
SE website 
Ongoing 
To update on ongoing 
developments about 
the Company which 
includes, 
performance of the 
Company and the 
sector, address 
concerns/grievances 
and update about the 
business risk 
Employees 
NO 
Conference calls, 
video conferencing, 
group discussions, 
one to one 
interactions, review 
on operations 
Ongoing 
Performance 
appraisal & rewards. 
Also improving 
operational 
efficiencies though 
training and 
awareness about 
health, safety and 
engagement 
initiatives 
Vendors and 
Suppliers 
NO 
Emails, letters, 
personal meetings, 
telephone, and 
conferences, among 
others. 
Ongoing 
Communication on 
materials, services, 
and feedback, among 
others. 
Government 
NO 
Emails, letters, 
representations, and 
meetings, among 
others. 
Ongoing 
To provide timely 
recommendations/ 
feedback on draft 
policies and various 
statutory approvals. 
Community 
YES 
Letters, and 
newspaper 
advertisement, 
among others. 
Ongoing 
To promote social 
welfare activities 
for inclusive growth, 
fair and equitable 
development and 
well-being of society 
through the 
Company’s business 
functioning. 
22
Leadership Indicators 
1.
Provide the processes for consultation between stakeholders and the Board on economic,
environmental, and social topics or if consultation is delegated, how is feedback from such
consultations provided to the Board.
Consultation is delegated and feedback is provided to Board Through Board Meetings.
2.
Whether stakeholder consultation is used to support the identification and management of
environmental, and social topics (Yes / No). If so, provide details of instances as to how the inputs
received from stakeholders on these topics were incorporated into policies and activities of the
entity.
Yes, we are doing the activities basis inputs recd from stakeholders through CSR initiatives.
3. Provide details of instances of engagement with, and actions taken to, address the concerns of
vulnerable/ marginalized stakeholder groups. NIL 
 PRINCIPLE 5 Businesses should respect and promote human rights 
Essential Indicators 
1.
Employees and workers who have been provided training on human rights issues and
policy(ies) of the entity, in the following format:
Category
FY 2022-23
Current Financial Year 
FY 2021-22
Previous Financial Year 
Total (A)
No. 
employees 
workers 
covered (B) 
of
/ 
% (B / A)
Total (C)
No. 
employees 
workers 
covered (D)
of
/ 
% (D / C)
Employees
Permanent
- 
- 
- 
- 
- 
- 
Other 
permanent 
- 
- 
- 
- 
- 
- 
Total Employees
- 
- 
- 
- 
- 
- 
Workers
Permanent
- 
- 
- 
- 
- 
- 
Other 
permanent 
- 
- 
- 
- 
- 
- 
Total Workers
- 
- 
- 
- 
- 
- 
2.
Details of minimum wages paid to employees and workers, in the following format:
Category 
FY 2022-23
Current Financial Year 
FY 2021-22   
Previous Financial Year 
Total 
(A) 
Equal
Minimum 
Wage 
to
More
than
Minimum 
Wage 
Total 
(D) 
Equal
Minimum 
Wage 
to
More
than
Minimum 
Wage 
No.
(B) 
% (B /
A) 
No.
(C) 
% (C
/
A) 
No.
(E) 
% (E  /
D) 
No.
(F) 
% (F  /
D) 
Employees
Permanent
Male
1003 
0 
0% 
1003
100% 
729 
0 
0% 
729 
100% 
Female
90 
0 
0% 
90 
100% 
65 
0 
0% 
65 
100% 
Other
Permanent 
than
23
Male
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Female
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Workers
Permanent
Male
304 
0 
0% 
304 
100% 
265 
0 
0 
265 
100% 
Female
864 
542 
62.73% 
322 
37.26% 
668 
537 
80.38% 
131 
19.61% 
Other 
Permanent 
than
Male
2581 
0 
0% 
2581
100% 
1723 
1057
61.34% 
486 
28.20% 
Female
545 
0 
0% 
545 
100% 
213 
0 
0% 
213 
100% 
24
3.
Details of remuneration/salary/wages, in the following format:
Male
Female
Number
Median remuneration/ salary/ 
wages of respective category 
Number
Median remuneration/ 
salary/ wages of 
respective category 
Board of Directors
(BoD) 
10 
12,00,000/- 
2 
12,00,000/- 
Key Managerial 
Personnel 
3 
 1,39,500/- 
- 
- 
Employees other 
than 
BoD 
and 
KMP 
 633 
 45,328/- 
 46 
 43,480/- 
Workers
281 
 26,302/- 
499 
 12,721/- 
4. Do you have a focal point (Individual/ Committee) responsible for addressing human
rights impacts or issues caused or contributed to by the business? (Yes/No) Yes
5.
Describe the internal mechanisms in place to redress grievances related to human rights
issues.
The Protected Disclosure should be submitted under a covering letter signed by the complainant in a
closed and secured envelope or sent through email with the subject “Protected disclosure under the
Whistle Blower policy”.
 The investigation shall be completed normally within 90 days of the receipt of the protected disclosure. 
 Microsoft Word - vigil machanism (polymedicure.com) 
6.
Number of Complaints on the following made by employees and workers:
FY 2022-23
Current Financial Year 
FY 2021-22
Previous Financial Year 
Filed 
during the 
year 
Pending 
resolution 
at the 
end of 
year 
Remarks 
Filed 
during 
the year 
Pending 
resolution 
at the 
end of 
year 
Remarks
Sexual Harassment
- 
- 
- 
- 
- 
Discrimination 
at 
workplace 
-
-
-
-
-
Child Labour
- 
- 
- 
- 
- 
Forced 
Labour/Involuntary 
Labour 
-
-
-
-
-
Wages
- 
- 
- 
- 
- 
Other
human
rights 
related 
issues 
-
-
-
-
-
7. Mechanisms to prevent adverse consequences to the complainant in discrimination and
harassment cases. VIGIL MECHANISM / WHISTLE BLOWER POLICY
8.
Do human rights requirements form part of your business agreements and contracts?
(Yes/No)
Yes
25
9. Assessments for the year:
% of your plants and offices that were assessed 
(by entity or statutory authorities or third parties) 
Child labour 
 100%
Forced/involuntary labour 
 100%
Sexual harassment 
100%
Discrimination at workplace 
 100%
Wages 
 100%
Others – please specify 
 -
10. Provide details of any corrective actions taken or underway to address significant risks /
concerns arising from the assessments at Question 9 above. NA
Leadership Indicators 
1.
Details of a business process being modified / introduced as a result of addressing
human rights grievances/complaints. Nil
2. Details of the scope and coverage of any Human rights due-diligence conducted. Nil
3.
Is the premise/office of the entity accessible to differently abled visitors, as per the
requirements of the Rights of Persons with Disabilities Act, 2016? YES
4.
Details on assessment of value chain partners:
% of value chain partners (by value of business done 
with such partners) that were assessed 
Sexual Harassment
53.76%
Discrimination at workplace
53.76%
Child Labour
 53.76%
Forced Labour/Involuntary Labour
 53.76%
Wages
 53.76%
Others – please specify
 Nil
5.
Provide details of any corrective actions taken or underway to address significant risks /
concerns arising from the assessments at Question 4 above.   NA
26
PRINCIPLE 6: Businesses should respect and make efforts to protect 
and restore the environment 
Essential Indicators 
1.
Details of total energy consumption (in Joules or multiples) and energy intensity, in the
following format:
Parameter
FY 2022-23
(Current Financial Year) 
FY 2021-22
(Previous Financial Year)
Total electricity consumption (A)
42758921 kwh 
35901642 kwh 
Total fuel consumption (B)
1709351 kwh 
958814 kwh 
Energy
consumption
through
other sources (C) 
N/A 
N/A 
Total
energy
consumption
(A+B+C) 
44468272 kwh 
36860456 kwh 
Energy intensity per rupee of
turnover 
(Total 
energy 
consumption/
turnover in rupees) 
 0.004164 kwh 
 0.004192 kwh 
Energy intensity (optional) – the
relevant metric may be selected 
by the entity 
 - 
- 
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external 
agency? (Y/N) If yes, name of the external agency. Yes- A2Z Engineering 
2.
Does the entity have any sites / facilities identified as designated consumers (DCs) under
the Performance, Achieve and Trade (PAT) Scheme of the Government of India? (Y/N) If
yes, disclose whether targets set under the PAT scheme have been achieved. In case targets
have not been achieved, provide the remedial action taken, if any.  - No
3.
Provide details of the following disclosures related to water, in the following format:
Parameter
FY 2022-23
(Current Financial Year) 
FY 2021-22
(Previous Financial 
Year) 
Water withdrawal by source (in kilolitres)
27
(i) Surface water
NIL 
NIL 
(ii) Groundwater
NIL 
NIL 
(iii) Third party water
41194 KL 
25711 KL 
(iv) Seawater / desalinated water
N/A 
N/A 
(v) Others
N/A 
N/A 
Total volume of water withdrawal
(in kilolitres) (i + ii + iii + iv + v) 
41194 KL 
25711 KL 
Total volume of water consumption
(in kilolitres) 
41194 KL 
25711 KL 
Water
intensity
per
rupee
of
turnover (Water consumed / turnover)
 0.0000039 KL 
 0.0000029 KL 
Water
intensity
(optional)
–
the
relevant metric may be selected by the 
entity 
 - 
- 
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external 
agency? (Y/N) If yes, name of the external agency. --No 
4.
Has the entity implemented a mechanism for Zero Liquid Discharge? If yes, provide details
of its coverage and implementation. --No
5.
Please provide details of air emissions (other than GHG emissions) by the entity, in the
following format:
Parameter
Please specify
unit 
FY 2022-23
(Current Financial 
Year) 
FY 2021- 22 
(Previous 
Financial Year) 
NOx
80< 
34 
34 
Sox
80< 
18 
18 
Particulate
matter
(PM) 
100< 
89 
89 
Persistent
organic
pollutants (POP) 
NA 
NA 
NA 
Volatile
organic
compounds (VOC) 
NA 
NA 
NA 
Hazardous
air
pollutants (HAP) 
NA 
NA 
NA 
Others
–
please
specify 
NA 
NA 
NA 
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an 
external agency? (Y/N) If yes, name of the external agency. 
 Yes- ECOTECH Services INC.
28
6.
Provide details of greenhouse gas emissions (Scope 1 and Scope 2 emissions) & its
intensity, in the following format:
Parameter
Unit
FY 
2022-23 
(Current 
Financial Year) 
FY 2021-22 
(Previous Financial 
Year) 
Total Scope 1 emissions 
(Break-up of the GHG into 
CO2, CH4, N2O, HFCs, PFCs, 
SF6, NF3, if available) 
Metric tonnes
of 
CO2
equivalent 
1967.31 
 1630.74 
Total Scope 2 emissions 
(Break-up of the GHG into 
CO2, CH4, N2O, HFCs, PFCs, 
SF6, NF3, if available) 
Metric tonnes
of 
CO2
equivalent 
21254.66 
 17618.33 
Total Scope 1 and Scope 2 
emissions per rupee of 
turnover 
 0.000002% 
 0.000002% 
Total Scope 1 and Scope 2 
emission intensity (optional) 
– the relevant metric may be
selected by the entity
- 
- 
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external 
agency? (Y/N) If yes, name of the external agency. YES- A – Z ENERGY ENGINEERS PVT LTD. 
7.
Does the entity have any project related to reducing Green House Gas emission? If Yes,
then provide details.  - No
8.
Provide details related to waste management by the entity, in the following format:
Parameter
FY 2022-23 
(Current Financial Year) 
FY 2021-22
(Previous Financial 
Year) 
Total Waste generated (in metric tonnes)
Plastic waste (A)
E-waste (B)
Nil 
Nil 
Bio-medical waste (C)
Nil 
Nil 
Construction
and
demolition
waste (D) 
45 
Nil 
Battery waste (E)
Nil 
Nil 
Radioactive waste (F) 
Nil 
Nil 
29
Other Hazardous
waste.
Please
specify, if any. (G) 
Nil 
Nil 
Other 
Non-hazardous 
waste 
generated (H). Please specify, if 
any. 
(Break-up by composition i.e. by 
materials relevant to the sector) 
Nil 
Nil 
Total (A+B + C + D + E + F + G
+ H)
45 
Nil 
For each category of waste generated, total waste recovered through recycling, re-using or
other recovery operations (in metric tonnes) 
Category of waste
(i) Recycled
20 
Nil 
(ii) Re-used
15 
Nil 
(iii) Other recovery operations
Nil 
Nil 
Total
For each category of waste generated, total waste disposed by nature of disposal method (in
metric tonnes) 
Category of waste
(i) Incineration
N/A 
N/a 
(ii) Landfilling
10 
N/A 
(iii) Other disposal operations
N/A 
N/A 
Total
45 
N/A 
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external 
agency? (Y/N) If yes, name of the external agency. Yes- Onus Design 
9. Briefly describe the waste management practices adopted in your establishments. Describe
the strategy adopted by your company to reduce usage of hazardous and toxic chemicals
in your products and processes and the practices adopted to manage such wastes.
There is no Hazardous or toxic chemical generated by establishment.
10. If the entity has operations/offices in/around ecologically sensitive areas (such as national
parks, wildlife sanctuaries, biosphere reserves, wetlands, biodiversity hotspots, forests,
coastal regulation zones etc.) where environmental approvals / clearances are required,
please specify details in the following format:
S.
No. 
Location
of
operations/offices
Type
of
operations 
Whether
the
conditions
of
environmental approval / clearance 
are being complied with? (Y/N) 
If no,   the   reasons   thereof   and 
corrective action taken, if any. 
NA 
NA 
NA 
30
11. Details of environmental impact assessments of projects undertaken by the entity based
on applicable laws, in the current financial year:
Name and brief details of 
project 
EIA
Notification 
No. 
Date
Whether 
conducted 
by 
independent 
external agency 
(Yes / No) 
Results 
communicated 
in 
public 
domain 
(Yes / No) 
Relevant 
Web 
link 
 NA 
 NA 
 NA 
NO 
 NO 
 - 
12. Is the entity compliant with the applicable environmental law/ regulations/ guidelines in
India; such as the Water (Prevention and Control of Pollution) Act, Air (Prevention and
Control of Pollution) Act, Environment protection act and rules thereunder (Y/N) YES. If
not, provide details of all such non-compliances, in the following format:
S. No.
Specify 
the 
law 
/
regulation 
/ 
guidelines which was 
not complied with 
Provide 
details 
of 
the 
non- 
compliance 
Any 
fines 
/ 
penalties / action 
taken by regulatory 
agencies such as 
pollution     control 
boards or by courts 
Corrective 
action 
taken, if any 
 Nil 
 Nil 
 Nil 
 Nil 
Leadership Indicators 
1.
Provide break-up of the total energy consumed (in Joules or multiples) from renewable
and non-renewable sources, in the following format:
Parameter
FY 2022-23
(Current 
Financial 
Year) 
FY 2021-22
(Previous Financial Year) 
From renewable sources
Total electricity
consumption
(A) 
2246741 kwh 
1760124 kwh 
Total fuel consumption (B)
N/A 
N/A 
Energy consumption through
other sources (C) 
N/A 
N/A 
Total energy consumed from
renewable sources (A+B+C) 
2246741 kwh 
1760124 kwh 
From non-renewable sources
31
Total
electricity consumption
(D) 
42221531 KWH 
35100333 KWH 
Total fuel consumption (E)
Energy consumption through
other sources (F) 
Total energy consumed from
non-renewable 
sources
(D+E+F) 
42221531 KWH 
35100333 KWH 
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external 
agency? (Y/N) If yes, name of the external agency. 
2.
Provide the following details related to water discharged:
Parameter
FY 2022-23 
(Current 
Financial Year) 
FY 2021-22 
(Previous 
Financial Year) 
Water discharge by destination and level of treatment (in kilolitres)
(i) To Surface water
N/A 
N/A 
-
No treatment
-
With treatment – please specify level of
treatment
(ii) To Groundwater
4,531 KL 
6,427 KL 
-
No treatment
- 
- 
-
With treatment – please specify level of
treatment
4,531 KL 
6,427 KL 
(iii) To Seawater
-
No treatment
- 
- 
-
With treatment – please specify level of
treatment
- 
- 
(iv) Sent to third-parties
- 
- 
-
No treatment
- 
- 
-
With treatment – please specify level of
treatment
- 
- 
(v) Others
- 
- 
-
No treatment
-
With treatment – please specify level of
treatment
Total water discharged (in kilolitres)
4,531 KL 
6,427 KL 
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external 
agency? (Y/N) If yes, name of the external agency.  No
32
3.
Water withdrawal, consumption and discharge in areas of water stress (in kilolitres):
For each facility / plant located in areas of water stress, provide the following information: 
(i)
Name of the area
(ii)
Nature of operations
(iii)
Water withdrawal, consumption and discharge in the following format:
Parameter
FY 2022-23
(Current Financial Year) 
FY 2021-22
(Previous Financial 
Year) 
Water withdrawal by source (in kilolitres)
(i) Surface water
- 
- 
(ii) Groundwater
-
-
(iii) Third party water
- 
- 
(iv) Seawater / desalinated water
- 
- 
(v) Others
- 
- 
Total volume of water withdrawal
(in kilolitres) 
-
-
Total volume of water consumption
(in kilolitres) 
-
-
Water
intensity
per
rupee
of
turnover (Water consumed / turnover)
 - 
- 
Water
intensity
(optional)
–
the
relevant metric may be selected by the 
¤ entity 
 - 
- 
Water discharge by destination and level of treatment (in kilolitres)
(i) Into Surface water
- 
- 
-
No treatment
- 
- 
-
With
treatment
–
please
specify level of treatment
- 
- 
(ii) Into Groundwater
- 
- 
-
No treatment
 - 
- 
-
With
treatment
–
please
specify level of treatment
 - 
- 
(iii) Into Seawater
- 
- 
-
No treatment
 - 
- 
-
With
treatment
–
please
specify level of treatment
 - 
- 
(iv) Sent to third-parties
-
- 
33
-
No treatment
 - 
- 
-
With
treatment
–
please
specify level of treatment
 - 
- 
(v) Others
 - 
- 
-
No treatment
 - 
- 
-
With
treatment
–
please
specify level of treatment
 - 
- 
Total water discharged (in kilolitres)
 - 
- 
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external 
agency? (Y/N) If yes, name of the external agency.       No 
4.
Please provide details of total Scope 3 emissions & its intensity, in the following format:
Parameter
Unit
FY 2022-23
(Current 
Financial 
Year) 
FY 2021-22 
(Previous Financial
Year) 
Total Scope 3 emissions 
(Break-up of the GHG into 
CO2, CH4, N2O, HFCs, PFCs,
SF6, NF3, if available) 
Metric
tonnes of 
CO2 
equivalent
N/A 
N/A 
Total Scope 3 emissions
per rupee of turnover 
- 
- 
Total Scope 3 emission 
intensity (optional) – the 
relevant metric may be 
selected by the entity 
- 
- 
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an 
external agency? (Y/N) If yes, name of the external agency.      No 
5.
With respect to the ecologically sensitive areas reported at Question 10 of Essential
Indicators above, provide details of significant direct & indirect impact of the entity on
biodiversity in such areas along-with prevention and remediation activities.   NA
6.
If the entity has undertaken any specific initiatives or used innovative technology or
solutions to improve resource efficiency, or reduce impact due to emissions / effluent
discharge / waste generated, please provide details of the same as well as outcome of such
initiatives, as per the following format:
Sr. No
Initiative undertaken
Details of the initiative (Web-link, if
any, may be provided along-with 
summary) 
Outcome 
of
the initiative 
34
1
Installation of PNG, 
RECD kit for diesel  
-
Reduces 70% diesel 
consumption with 
reduction of CO 2 
generation, 
2
Installation of UFRO 
& High TDS RO 
-
2) Recycle 168 Kl/day
of used water and
reduce equivalent
usage of ground water.
7. Does the entity have a business continuity and disaster management plan? Give details
in 100 words/ web link.
Yes, the Company recognizes the importance of business continuity in its business and
has put in place policies to ensure mission-critical operations continue in the event of
an interruption Link of Risk Management Policy is as follows:
https://www.polymedicure.com/disclosures-under-regulation-46-of-lodr/
8. Disclose any significant adverse impact to the environment, arising from the value chain
of  the entity. What mitigation or adaptation measures have been taken by the entity
in this regard.
9. Percentage of value chain partners (by value of business done with such partners) that
were assessed for environmental impacts:  53.76%
PRINCIPLE 7 Businesses, when engaging in influencing public and 
regulatory policy, should do so in a manner that is responsible 
and transparent 
Essential Indicators 
1.
a. Number of affiliations with trade and industry chambers/associations.
b. List the top 10 trade industry chambers/ associations (determined based on
the total members of such body) the entity is a member of/ affiliated to.
S. 
No. 
Name of the trade and Industry chambers / 
associations 
Reach of trade and 
industry chambers / 
associations (State / 
National) 
1 
Confederation of Indian Industry (CII) 
National 
35
2 
Federation of Chambers of Commerce & 
Industry 
National 
3 
 PHD Chamber of Commerce and Industry 
National 
4 
Faridabad Industrial Association 
State 
5 
Healthcare Federation of India 
National 
2.
Provide details of corrective action taken or underway on any issues related to anti-
competitive conduct by the entity, based on adverse orders from regulatory
authorities.
Name of authority
Brief of the case
Corrective action taken
None
NA
NA
Leadership Indicators 
Details of public policy positions advocated by the entity: 
S.No.
Public 
policy 
advocated 
Method 
resorted for 
such 
advocacy 
Whether 
information 
available in 
public 
domain? 
(Yes/No) 
Frequency 
of Review 
by Board 
(Annually/ 
Half Yearly 
/ Quarterly 
/ Others- 
please 
specify 
Web Link, if 
available 
NA 
PRINCIPLE 8 Businesses should promote inclusive growth and 
equitable development 
Essential Indicators 
1. Details of Social Impact Assessments (SIA) of projects undertaken by the entity based
on applicable laws, in the current financial year. Not Applicable
Name and 
brief details 
of project 
SIA 
Notification 
No. 
Date of 
notification 
Whether 
conducted by 
independent 
external 
agency (Yes / 
No) 
Results 
communicated 
in public 
domain 
(Yes/No) 
Relevant 
web link 
-
-
-
-
-
-
2.
Provide information on project(s) for which ongoing Rehabilitation Resettlement (R&R)
is being undertaken by your entity, in the following format: Not Applicable
36
S.No.
Name of 
Project for 
which R&R 
is ongoing 
State
District
No. of Project 
Affecyed 
Families (PAFs) 
% of PAFs 
covered by 
R&R 
Accounts 
paid to PAFs 
in the FY(in 
INR) 
-
-
-
-
-
-
3.
Describe the mechanisms to receive and redress grievances of the community.
4.
Percentage of input material (inputs to total inputs by value) sourced from suppliers:
FY 2022-23 Current 
Financial Year 
FY 2021-22 Previous 
Financial Year 
Directly sourced from MSMEs/small 
producers 
28.05%
25.60%
Sourced directly from within the district 
and neighboring districts 
22.59%
21.49%
Leadership Indicators 
1. Provide details of actions taken to mitigate any negative social impacts
identified in the Social Impact Assessments (Reference : Question 1 of Essential
Indicators above):
Details of negative social impact identified 
Corrective action taken 
NA 
NA 
2. Provide the following information on CSR projects undertaken by your entity in
designated aspirational districts as identified by government bodies:
S. No.  
State
Aspirational District 
Amount spent(In INR) 
NA 
NA 
NA 
3. (a) Do you have a preferential procurement policy where you give preference
to purchase from suppliers comprising marginalized / vulnerable groups?
(Yes/No)
(b) From which marginalized / vulnerable groups do you procure?
(c) What percentage of total procurement (by value) does it constitute?
4. Details of the benefits derived and shared from the intellectual properties
owned or acquired by your entity (in the current financial year), based on
traditional knowledge:
37
S. 
No. 
Intellectual 
Property based 
on 
traditional 
knowledge 
Owned/Aquired(Yes/No)
Benefit 
sahred(Yes/No)
Basis 
of 
calculating 
benefit 
share 
1 
Patent 
Yes 
No 
- 
2 
Trademark 
Yes 
No 
- 
5. Details of corrective actions taken or underway, based on any adverse order in
intellectual property related disputes wherein usage of traditional knowledge is
involved.
Name of authority 
Brief of the case 
Corrective action taken 
NA 
NA 
NA 
6. Details of beneficiaries of CSR Projects:
S. No.
CSR projects 
No. 
of 
persons 
benefitted 
from 
CSR Projects 
% of beneficiaries 
from 
vulnerable 
and 
marginalized 
groups 
1.
Contributors to CSR Eligible
Trust, Foundation & Society
- 
100% 
2 
COVID Specific 
- 
100% 
3 
On promotion education 
- 
100% 
4 
Social welfare 
- 
100% 
PRINCIPLE 9 Businesses should engage with and provide value to 
their consumers in a responsible manner 
Essential Indicators 
1.
Describe the mechanism in place to receive and respond to consumer complaints and
feedback.
Customer complaints with respect to Product Quality / Dispatches are mailed to the
concerned Marketing team either directly or through dealers/agents attached to these
customers with details on batch number, invoices, etc. All such complaints are accorded
priority which is then escalated to the concerned QC team at the plant (product quality
related) or Sales Logistics team (dispatch related). For quality-related complaints, the
concerned QC team members also visit the customer depending on the seriousness of
the complaint and suggest corrective action either directly at the customer site or by
analysing the samples of the affected material at our lab.
38
2.
Turnover of products and / services as a percentage of turnover from all
products/services that carry information about:
As a percentage to total turnover
Environmental and social parameters relevant 
to the product 
-
Safe and responsible usage
-
Recycling and/or safe disposal
-
3.
Number of consumer complaints in respect of the following:
FY 
2022-23 
(Current 
Financial Year 
Remarks
FY 2021-22 (Previous 
Financial Year) 
Remarks
Received 
during the 
year 
Pending 
resolution 
at end of 
year 
Received 
during the 
year 
Pending 
resolution 
at end of 
year 
Data 
privacy 
NIL 
Advertising
Cyber-
security 
Delivery of 
essential 
Services 
Restrictive 
Trade 
Practices 
Unfair 
Trade 
Practices 
Other
4.
Details of instances of product recalls on account of safety issues: Nil
Number
Reasons for recall
Voluntary recalls
Forced recalls
5.
Does the entity have a framework / policy on cyber security and risks related to data
privacy? (Yes/No) if available, provide a web-link of the policy. Yes
6.
Provide details of any corrective actions taken or underway on issues relating to
advertising, and delivery of essential services; cyber security and data privacy of
customers; re-occurrence of instances of product recalls; penalty / action taken by
regulatory authorities on safety of products / services.
39
Leadership Indicators 
1.
Channels / platforms where information on products and services of the entity can be
accessed (provide web link, if available). https://www.polymedicure.com/
2.
Steps taken to inform and educate consumers about safe and responsible usage of
products and/or services.
3.
Mechanisms in place to inform consumers of any risk of disruption/discontinuation of
essential services.
4.
Does the entity display product information on the product over and above what is
mandated as per local laws? (Yes/No/Not Applicable) If yes, provide details in brief. Did
your entity carry out any survey with regard to consumer satisfaction relating to the
major products / services of the entity, significant locations of operation of the entity
or the entity as a whole? (Yes/No)
5.
Provide the following information relating to data breaches:
a.
Number of instances of data breaches along-with impact - NA
b.
Percentage of data breaches involving personally identifiable information of
customers – NA
40
